Minerva Neurosciences (NERV) Tops Q3 EPS by 9c
Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($1.29), $0.09 better than the analyst estimate of ($1.38).
For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.
